Monthly Archives: October 2016

Today’s Tales from the Road comes from Corporate Recruiter, Raiza Rivera, who attended Come Tech Out the Triangle earlier this month. We exhibited at this tech-focused job fair in hopes of recruiting for several open technology positions at Premier.   “I came to the job fair today because I saw that Premier Research was on theRead more

DURHAM, N.C., October 28, 2016 — STARR Coalition, an organization dedicated to treatment, advocacy, research, and recovery in mental health, named Premier Research CRO of the Year at its annual STARR Meeting in Boca Raton, Florida. The group cited Premier Research for its longstanding partnership in supporting the coalition’s mission to serve the mental healthRead more

Britain’s plans to leave the European Union could profoundly affect clinical drug research in the U.K. The impact spans a broad range of unknowns, from where the London-based EMA will put down roots to Brexit’s influence on trial regulations, cost, funding, and recruiting of scientific talent. Our Chief Medical Officer, Dr. Colin Hayward, addressed theseRead more

DURHAM, N.C., OCTOBER 27, 2016 — Medical device and diagnostic companies are conducting more clinical trials than ever, a trend that’s giving rise to new procedures and best practices for studies that differ in many ways from pharmaceutical trials. Register for this webinar focused on the evolution of device clinical research on Wednesday, November 2.Read more

Rare disease is one of our main areas of focus here at Premier, so you’ll often see my colleagues and me talking about rare, through our webinars and white papers, and basically, almost any phone conversation with us. Last week, I attended the NORD Summit in Arlington, VA, and as usual, I found myself inspiredRead more

DURHAM, N.C., October 26, 2016 — Premier Research’s lead strategist will participate in a panel discussion on the evolving landscape for investigator sites at CNS Summit 2016 in Boca Raton, Florida. Krista Armstrong, Vice President of Strategic Development, will join colleagues in addressing topics such as: Advantages and disadvantages of site consolidation Site selection and strategicRead more

This week, we get a Tales from the Road two-for-one, from Dr. Colin Hayward, our Chief Medical Officer, who went to the Oxford Biotech Network Awards one week, and the ESMO Conference the next. Have a look: OBN Premier Research had the opportunity once again to support the Oxford Biotech Network (OBN) awards night. ThatRead more

Rising addiction rates are adding to already huge unmet needs in treating drug dependence, but big pharmaceutical companies show little interest in developing medications for common dependencies such as cannabis and methamphetamine. This volatile environment begs for trailblazers who can fill the void, but inconsistent patient behavior, lack of clear regulatory pathways, and other factorsRead more

Investment Will Advance Premier’s Next Development Phase RESEARCH TRIANGLE PARK, N.C., Oct. 17, 2016 — Premier Research (“Premier” or the “Company”), a leading middle-market contract research organization (“CRO”) that provides comprehensive clinical development, analytic, and support services to pharmaceutical, biotech, and medical device customers worldwide, today announced that it will receive a growth investment fromRead more

Introducing Tales from the Road, a series of blogshorts, where our Premier People report in from their travels outside the office. Because sometimes, not everything that happens on the road stays on the road! Today’s inaugural post comes from Juliet Moritz, Executive Director, Strategic Development Department, Rare Diseases, reporting back on her trip to Amsterdam lastRead more

Phone Us Now
Email Us Now